Roche nixes Tecentriq trial in early breast cancer, but it's 'still in the...

Quote
cafead

cafead

Administrator
Staff member
  • cafead   Apr 26, 2023 at 10:22: AM
via Roche’s plans for expanding Tecentriq in early-stage cancers have hit a snag. But the company’s newly minted pharma chief remains hopeful for an important trial in resectable lung cancer.

article source
 

<



Similar threads

cafead
Roche reports positive data from Phase III influenza treatment trial
Replies
0
Views
9
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
Obesity pill race heats up as Novo, Roche and Terns share data
Replies
0
Views
44
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
Roche doubles down with another subcutaneous FDA nod, this one for MS star Ocrevus
Replies
0
Views
33
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
FDA approves Roche’s Tecentriq Hybreza for cancer
Replies
0
Views
21
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
‘The trajectory is encouraging.’ Roche hopes obesity drug will show 25% weight loss one day
Replies
1
Views
71
Pharma/Biotech Companies - In the News
anonymous
Top Bottom
Back
Quote